A MULTICENTER, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF BASILIXIMAB (SIMULECT®) IN COMBINATION WITH TRIPLE THERAPY INCLUDING AZATHIOPRINE FOR THE PREVENTION OF ACUTE REJECTION EPISODES IN RENAL ALLOGRAFT PATIENTS.
- 15 April 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 67 (7) , S158
- https://doi.org/10.1097/00007890-199904150-00632
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: